Crucible · Firm report card

LONGEVICA PHARMACEUTICALS, INC.

NJ · SBIR awardee across 1 federal program (HHS/NIH), first award 2014.

2SBIR awards
$444,026SBIR $
2 → 0Phase I → II
$0Follow-on federal $
0Follow-on contracts

SBIR awards by program

ProgramAwardsSBIR $Phase IPhase II
HHS/NIH 2 $444,026 2 0

Mission areas

Open the interactive profile of LONGEVICA PHARMACEUTICALS, INC. →

Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.

Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology